Company Performance: Revenue, profit margins, and overall financial health directly impact investor confidence and stock price.

Industry Trends: The performance and outlook of the pharmaceutical industry affect valuations, especially considering sector growth forecasts.

Regulatory Changes: Government policies, drug approvals, and healthcare regulations significantly influence revenue potential and investor sentiment.

Market Sentiment: General investor optimism or pessimism and overall market conditions in China affect buying and selling decisions.

Economic Conditions: Economic growth, inflation, and interest rates in China can influence investment flows and stock valuations.

Competitor Actions: News and performance of competing pharmaceutical companies can shift investor focus and relative valuations.

Global Events: International events, geopolitical risks, and global health crises can create uncertainty and affect investor behavior.

Company News: Announcements regarding new products, partnerships, or strategic initiatives impact perceptions of future growth and profitability.

Dividend Policy: Dividend payouts and announcements influence the attractiveness of the stock to income-seeking investors.

Investor Confidence: Overall belief in the company's management, strategy, and future prospects.